SHYJAN; Andrew W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHYJAN; Andrew W..The latest application filed is for "method for isolating cell-type specific mrnas".

Company Profile

2.14.18

SHYJAN; Andrew W. - San Carlos CA US
Shyjan; Andrew W. - Nahant MA
Shyjan; Andrew W. - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Isolating Cell-type Specific Mrnas App 20190119670 - HEINTZ; Nathaniel ; et al.	2019-04-25
Method for Isolating Cell-Type Specific mRNAs App 20140196176 - Heintz; Nathaniel ; et al.	2014-07-10
Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag Grant 8,513,485 - Heintz , et al. August 20, 2	2013-08-20
Multidrug resistance-associated polypeptide Grant 8,287,862 - Shyjan October 16, 2	2012-10-16
Method for Isolating Cell-Type Specific mRNAS App 20110314565 - Heintz; Nathaniel ; et al.	2011-12-22
Method for isolating cell type-specific mRNAs Grant 7,985,553 - Heintz , et al. July 26, 2	2011-07-26
Novel Multidrug Resistance-associated Polypeptide App 20110020341 - Shyjan; Andrew W.	2011-01-27
Multidrug resistance-associated polypeptide Grant 7,785,812 - Shyjan August 31, 2	2010-08-31
Novel multidrug resistance-associated polypeptide App 20050191307 - Shyjan, Andrew W.	2005-09-01
Compositions and methods for the diagnosis, prevention and treatment of tumor progression App 20050106600 - Shyjan, Andrew W.	2005-05-19
Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer App 20050100931 - Shyjan, Andrew W.	2005-05-12
HRPCa9 and HRPCa10 nucleic acids and polypeptides Grant 6,872,811 - MacBeth , et al. March 29, 2	2005-03-29
Method for isolating cell-type specific mrnas App 20050009028 - Heintz, Nathaniel ; et al.	2005-01-13
FOHY03 polypeptides Grant 6,825,320 - Shyjan November 30, 2	2004-11-30
fohy030 nucleic acid molecules Grant 6,794,185 - Shyjan September 21, 2	2004-09-21
Chk1 and uses thereof App 20040091948 - Shyjan, Andrew W. ; et al.	2004-05-13
Chk1 and uses thereof Grant 6,723,498 - Shyjan , et al. April 20, 2	2004-04-20
Genes expressed in lung cancer App 20030175704 - Lasek, Amy K. W. ; et al.	2003-09-18
Nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer App 20030138865 - MacBeth, Kyle J. ; et al.	2003-07-24
Methods and compositions for the identification, assessment, prevention, and therapy of human cancers App 20030129629 - Roth, Frederick P. ; et al.	2003-07-10
Compositions and methods for the diagnosis, prevention and treatment of tumor progression App 20030119740 - Shyjan, Andrew W.	2003-06-26
Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer Grant 6,506,607 - Shyjan January 14, 2	2003-01-14
Methods and compositions for the identification, assessment, prevention and therapy of human cancers App 20020120004 - Roth, Frederick P. ; et al.	2002-08-29
Methods and compositions for the identification, assessment, prevention and therapy of human cancers App 20020051978 - Roth, Frederick P. ; et al.	2002-05-02
Methods And Compositions For The Identification And Assessment Of Cancer Therapies App 20020006613 - SHYJAN, ANDREW W. ; et al.	2002-01-17
Compositions and methods for the diagnosis prevention and treatment of tumor progression Grant 6,312,909 - Shyjan November 6, 2	2001-11-06
Methods for detecting fohy030 Grant 6,251,597 - Shyjan June 26, 2	2001-06-26
Human gene FOHY030 coding for tumor progression inhibitor Grant 5,674,739 - Shyjan October 7, 1	1997-10-07
Murine gene fomy030 coding for tumor progression inhibitor Grant 5,633,161 - Shyjan May 27, 1	1997-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.